NCT00356369View on ClinicalTrials.gov

Study in Adolescents/Adults to Evaluate Non-inferiority&Persistence up to 5 Years of GSK Bio MenACWY Conjugate Vaccine

PHASE2CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

December 23, 2006

Primary Completion Date

September 7, 2007

Study Completion Date

February 28, 2008

Conditions
Infections, Meningococcal
Interventions
BIOLOGICAL

meningococcal ACWY (vaccine)

One intramuscular dose.

BIOLOGICAL

Mencevax™ ACWY

One subcutaneous dose.

Trial Locations (3)

1000

GSK Investigational Site, Manila

1781

GSK Investigational Site, City of Muntinlupa

Unknown

GSK Investigational Site, Riyadh

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY